We are live on ! Find out more
SLT

St Louis Trust Portfolio holdings

AUM $856M
1-Year Est. Return 18.9%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+18.9%
3 Year Est. Return
+52.3%
5 Year Est. Return
+51.23%
10 Year Est. Return
+178.74%
AUM
$751M
AUM Growth
+$60.4M
Cap. Flow
-$1.56M
Cap. Flow %
-0.21%
Top 10 Hldgs %
65.8%
Holding
126
New
6
Increased
24
Reduced
14
Closed
4

Top Buys

Rank Stock Value
1
SCHX icon
Schwab US Large- Cap ETF
SCHX
+$5.52M
2
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$5.06M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$2.74M
4
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$2.41M
5
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$1.51M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$21.6M
2
IJT icon
iShares S&P Small-Cap 600 Growth ETF
IJT
+$1.57M
3
IJS icon
iShares S&P Small-Cap 600 Value ETF
IJS
+$1.47M
4
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.29M
5
VSS icon
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
+$680K

Sector Composition

Rank Sector Weight
1 Financials 2.39%
2 Consumer Staples 1.36%
3 Healthcare 1.34%
4 Industrials 1.06%
5 Technology 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
126
DELISTED
Intra-Cellular Therapies Inc.
ITCI
– –
-163,488
Closed -$21.6M
2 3 4 5
6

Similar funds

QIM
Quest Investment Management Lake Oswego, Oregon $857M AUM 21.67% 1-Year Est. Return
BIM
Baldwin Investment Management West Conshohocken, Pennsylvania $856M AUM 9.05% 1-Year Est. Return
TIM
Total Investment Management Scottsdale, Arizona $858M AUM 9.96% 1-Year Est. Return
NOCM
Night Owl Capital Management Greenwich, Connecticut $858M AUM 31.41% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
ACP
Aviance Capital Partners Naples, Florida $854M AUM 25.16% 1-Year Est. Return
BCM
Benchstone Capital Management New York $860M AUM 32.46% 1-Year Est. Return
AWM
Absher Wealth Management Chapel Hill, North Carolina $853M AUM 14.81% 1-Year Est. Return

St Louis Trust's Q2 2025 Portfolio in Review

As of Q2 2025, St Louis Trust held 126 positions worth $751M, up 8.7% from $690M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

St Louis Trust's Q2 2025 filing shows 6 new, 24 increased, 14 reduced and 4 closed positions. Its largest new stake was Vanguard S&P Small-Cap 600 Value ETF: 16,300 shares worth $1.39M. The largest sale was Intra-Cellular Therapies Inc., an estimated $21.6M.

By sector, the portfolio is most concentrated in Financials at 2.4% of assets, down from 2.5% a quarter earlier, followed by Consumer Staples and Healthcare.

  • St Louis Trust's largest Q2 2025 buy was Vanguard S&P Small-Cap 600 Value ETF: 16,300 shares worth $1.39M.
  • St Louis Trust added most to Schwab US Large- Cap ETF in Q2 2025, an estimated $5.52M increase.
  • St Louis Trust's biggest Q2 2025 reduction was iShares S&P Small-Cap 600 Value ETF, cutting an estimated $1.47M.
  • St Louis Trust fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $21.6M.
  • St Louis Trust's ten largest holdings make up 66% of its $751M portfolio in Q2 2025.
  • St Louis Trust opened 6 new positions and closed 4 in Q2 2025.
  • St Louis Trust's portfolio value rose 8.7% quarter-over-quarter to $751M.

Based on St Louis Trust's 13F filing for Q2 2025, filed 25 Jul 2025.